China Glucose Monitoring System Market by Size, Regions, Type, Application and Forecast 2019-2025
Market Reports on China Provides the Trending Market Research Report on“China Glucose Monitoring System Market Report 2019-2025”under Life Science Category. The report offers a collection of superior market research, market analysis, competitive intelligence and Market reports.
MARKET OUTLOOK
Has estimated the China market for continuous Glucose Monitoring System comprising (CGMS) and self-monitoring of blood glucose (SMBG) to show an upward trend in terms of revenue and grow rapidly with a CAGR of 25.62% and 9.36% respectively, in the forecasting years 2019-2025.
Request a free sample copy of Glucose Monitoring System Market Report @
http://www.marketreportsonchina.com/marketreports/sample/reports/1676527
China is the country with the largest diabetic population in the world. Around 11% of the country’s population is reported to suffer from the metabolic illness, and around 36% of the people are in the pre-diabetic stage. In the past two decades, China has become one of the most powerful economies in the world and is currently the biggest consumer market in the world. It is also the biggest prospective market for medical devices business, and CGMS has significant growth potential in the country. The Chinese healthcare industry has been developing rapidly for the past ten years, and the market continues to show strong growth potential. The Chinese government has launched a drive for industry consolidation, which is now being highlighted in the new Five-Year Plan. The Chinese drug distribution industry is still immature by international standards, and is now getting into a rapidly changing stage, which brings both opportunities and challenges to all parties in the health industry value chain. In addition, factors such as high costs of devices and lack of reimbursement policies hinder the growth of the glucose monitoring market in the country.
COMPETITIVE OUTLOOK
Some of the companies having their presence in the China glucose monitoring system market are Apex Biotechnology Corp., ARKRAY, Inc., Becton Dickinson and Company, Yones Toptech (China) Co., Ltd., Medtronic, Abbott, Johnson & Johnson, Sinocare, Roche Diagnostics and B Braun Melsungen AG.
Browse our full report with Table of Contents:
http://www.marketreportsonchina.com/marketreports/china-glucose-monitoring-system-market-2019-2025/1676527
About Market Reports on China:
Market Reports on China is thus the one-stop solution for the entire market research requirements with regards to China.We provide you with insight and analysis on the country’s economic outlook at the national, regional and city level, presenting deep understanding of disparities and evolutionary paths. Get a complete, consistent and concise view of your markets with comprehensive industry reports. Our latest regional databanks, forecasts, and detailed risk ratings will help you to identify risk and opportunities in every industry and develop strategic plans to deal with the competitiveness in the Chinese market.
Contact us:
Market Reports on China
Tel: +91 22 27810772 / 27810773
Email:info@marketreportsonchina.com
Website: http://www.marketreportsonchina.com
Follow us on: Twitter, Facebook, LinkedIn
MARKET OUTLOOK
Has estimated the China market for continuous Glucose Monitoring System comprising (CGMS) and self-monitoring of blood glucose (SMBG) to show an upward trend in terms of revenue and grow rapidly with a CAGR of 25.62% and 9.36% respectively, in the forecasting years 2019-2025.
Request a free sample copy of Glucose Monitoring System Market Report @
http://www.marketreportsonchina.com/marketreports/sample/reports/1676527
China is the country with the largest diabetic population in the world. Around 11% of the country’s population is reported to suffer from the metabolic illness, and around 36% of the people are in the pre-diabetic stage. In the past two decades, China has become one of the most powerful economies in the world and is currently the biggest consumer market in the world. It is also the biggest prospective market for medical devices business, and CGMS has significant growth potential in the country. The Chinese healthcare industry has been developing rapidly for the past ten years, and the market continues to show strong growth potential. The Chinese government has launched a drive for industry consolidation, which is now being highlighted in the new Five-Year Plan. The Chinese drug distribution industry is still immature by international standards, and is now getting into a rapidly changing stage, which brings both opportunities and challenges to all parties in the health industry value chain. In addition, factors such as high costs of devices and lack of reimbursement policies hinder the growth of the glucose monitoring market in the country.
COMPETITIVE OUTLOOK
Some of the companies having their presence in the China glucose monitoring system market are Apex Biotechnology Corp., ARKRAY, Inc., Becton Dickinson and Company, Yones Toptech (China) Co., Ltd., Medtronic, Abbott, Johnson & Johnson, Sinocare, Roche Diagnostics and B Braun Melsungen AG.
Browse our full report with Table of Contents:
http://www.marketreportsonchina.com/marketreports/china-glucose-monitoring-system-market-2019-2025/1676527
About Market Reports on China:
Market Reports on China is thus the one-stop solution for the entire market research requirements with regards to China.We provide you with insight and analysis on the country’s economic outlook at the national, regional and city level, presenting deep understanding of disparities and evolutionary paths. Get a complete, consistent and concise view of your markets with comprehensive industry reports. Our latest regional databanks, forecasts, and detailed risk ratings will help you to identify risk and opportunities in every industry and develop strategic plans to deal with the competitiveness in the Chinese market.
Contact us:
Market Reports on China
Tel: +91 22 27810772 / 27810773
Email:info@marketreportsonchina.com
Website: http://www.marketreportsonchina.com
Follow us on: Twitter, Facebook, LinkedIn
Comments
Post a Comment